Cardinal Health (CAH) Stock Price, News & Analysis

Company Overview

Cardinal Health, Inc. is a global healthcare services and products company that provides a broad portfolio of pharmaceuticals, medical products and supply chain technologies. Through its pharmaceutical segment, the company distributes branded and generic drugs, over-the-counter medications and specialty pharmaceuticals to retail pharmacies, hospitals and physician offices. Its medical segment manufactures and distributes medical, surgical and laboratory products, including gloves, fluid management systems, surgical apparel and nuclear medicine products.

In addition to distribution and manufacturing, Cardinal Health offers supply chain consulting, data analytics and business technology solutions designed to optimize inventory management, reduce costs and improve patient care. The company’s technology offerings span pharmacy automation, performance analytics and patient services platforms, supporting health systems, clinics and pharmacies in managing workflows and compliance.

Founded in 1971 and headquartered in Dublin, Ohio, Cardinal Health has grown through strategic acquisitions and organic expansion to serve healthcare providers and manufacturers across North America, with additional operations in Europe and the Asia-Pacific region. Over the decades, the company has expanded its product portfolio and logistics network to help customers navigate complex regulatory environments and evolving industry trends.

Leadership at Cardinal Health is focused on operational excellence, innovation and customer service. Under the direction of Chief Executive Officer Michael Kaufmann, the company is pursuing initiatives in digital transformation, sustainable supply chain practices and enhanced patient outcomes, while maintaining its commitment to quality, safety and financial discipline.

Key Stats

• Today's Range: $150.23 to $152.39
• 50-Day Range: $146.18 to $167.62
• 52-Week Range: $106.54 to $168.44
• Volume: 1.21 million shs
• Average Volume: 2.39 million shs
• Market Capitalization: $35.93 billion
• P/E Ratio: 23.33
• Dividend Yield: 1.36%
• Price Target: $165.93
• Consensus Rating: Moderate Buy

Cardinal Health Stock Analysis - MarketRank™

Cardinal Health scored higher than 99% of companies evaluated by MarketBeat, and ranked 18th out of 960 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 11 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Cardinal Health has a consensus price target of $165.93, representing about 10.3% upside from its current price of $150.45.

Amount of Analyst Coverage

Cardinal Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 12.58%

Earnings Growth

Earnings for Cardinal Health are expected to grow by 12.58% in the coming year, from $7.95 to $8.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cardinal Health is 23.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.44.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cardinal Health is 23.33, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 74.99.

Price to Earnings Growth Ratio

Cardinal Health has a PEG Ratio of 1.29. PEG Ratios above 1 indicate that a company could be overvalued.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.02% of the float of Cardinal Health has been sold short.

Short Interest Ratio / Days to Cover

Cardinal Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cardinal Health has recently decreased by 5.64%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Cardinal Health pays a meaningful dividend of 1.34%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cardinal Health has been increasing its dividend for 29 years.

Dividend Coverage

The dividend payout ratio of Cardinal Health is 31.63%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 22.79% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -2.65

Percentage of Shares Shorted

3.02% of the float of Cardinal Health has been sold short.

Short Interest Ratio / Days to Cover

Cardinal Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cardinal Health has recently decreased by 5.64%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.51

News Sentiment

Cardinal Health has a news sentiment score of 1.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.94 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 30 news articles for Cardinal Health this week, compared to 31 articles on an average week.

Search Interest

Only 9 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of -31% compared to the previous 30 days.

MarketBeat Follows

6 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Cardinal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $40,489,525.00 in company stock.

Percentage Held by Insiders

Only 0.09% of the stock of Cardinal Health is held by insiders.

Percentage Held by Institutions

87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CAH Stock Analysis - Frequently Asked Questions

How have CAH shares performed this year?

Cardinal Health's stock was trading at $118.27 at the beginning of the year. Since then, CAH stock has increased by 27.2% and is now trading at $150.45.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) posted its earnings results on Tuesday, August, 12th. The company reported $2.08 EPS for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. The business's revenue for the quarter was up .5% on a year-over-year basis.
Read the conference call transcript.

Does Cardinal Health have any subsidiaries?

Cardinal Health subsidiaries include these companies: Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and more.

Who are Cardinal Health's major shareholders?

Top institutional investors of Cardinal Health include Vanguard Group Inc. (12.81%), State Street Corp (5.31%), Geode Capital Management LLC (2.68%) and Bank of America Corp DE (1.46%). Insiders that own company stock include Jason M Hollar, Jessica L Mayer, Aaron E Alt, Deborah Weitzman, Stephen M Mason, Ola M Snow, Michelle D Greene, Mary C Scherer and Michelle Brennan.
View institutional ownership trends.

How do I buy shares of Cardinal Health?

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cardinal Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Broadcom (AVGO), AbbVie (ABBV) and Chevron (CVX).

Company Calendar

• Record date for 7/15 Dividend: 7/01/2025
• Ex-Dividend for 7/15 Dividend: 7/01/2025
• Dividend Payable: 7/15/2025
• Last Earnings: 8/12/2025
• Today: 9/15/2025
• Record date for 10/15 Dividend: 10/01/2025
• Ex-Dividend for 10/15 Dividend: 10/01/2025
• Dividend Payable: 10/15/2025
• Next Earnings (Estimated): 11/07/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:CAH
• CIK: 721371
• Web: www.cardinalhealth.com
• Phone: (614) 757-5000
• Fax: 614-757-6000
• Employees: 57,700
• Year Founded: 1971

Price Target and Rating

• Average Price Target for Cardinal Health: $165.93
• High Price Target: $203.00
• Low Price Target: $124.00
• Potential Upside/Downside: +9.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.79
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $6.45
• Trailing P/E Ratio: 23.46
• Forward P/E Ratio: 19.05
• P/E Growth: 1.29
• Net Income: $1.56 billion
• Net Margins: 0.70%
• Pretax Margin: 0.94%
• Return on Equity: -74.45%
• Return on Assets: 4.14%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.94
• Quick Ratio: 0.50

Sales & Book Value

• Annual Sales: $222.58 billion
• Price / Sales: 0.16
• Cash Flow: $11.60 per share
• Price / Cash Flow: 13.05
• Book Value: ($11.04) per share
• Price / Book: -13.72

Miscellaneous

• Outstanding Shares: 238,794,000
• Free Float: 238,579,000
• Market Cap: $36.16 billion
• Optionable: Optionable
• Beta: 0.73